SCHEMBL2160610

SCHEMBL2160610

N#CCC(=O)c1cccc(Cl)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
CTSA P10619 3/20 0.38
ABL1 P00519 1/20 0.37
ALDH1A1 P00352 4/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 1/20 0.37
AGTR1 P30556 1/20 0.37
TSHR P16473 2/20 0.36
CYP3A4 P08684 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALOX15 P16050 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KCNH2 Q12809 2/20 0.35
RECQL P46063 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
IDH1 O75874 1/20 0.34
IDH2 P48735 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15813633 0.79 ALDH1A1 (0.45) MAPTCTSAALDH1A1GAAHPGD
SCHEMBL6271757 0.79 P2RX7 (0.53) MAPTCTSAALDH1A1GAAHPGD
SCHEMBL7978530 0.78 ALDH1A1 (0.49) MAPTCTSAALDH1A1GAAHPGD
SCHEMBL31604393 0.78 ALDH1A1 (0.49) MAPTCTSAALDH1A1GAAHPGD
SCHEMBL9446811 0.77 GSK3B (0.42) MAPTCTSAALDH1A1GAAHPGD
SCHEMBL31749190 0.76 CTSA (0.41) CTSAALDH1A1GAAMEN1KMT2A
SCHEMBL28210699 0.73 TSHR (0.46) MAPTCTSAALDH1A1GAAHPGD
SCHEMBL950329 0.72 MAPT (0.42) MAPTABL1ALDH1A1GAATSHR
Water SCHEMBL27529339 0.72 ALDH1A1 (0.49) MAPTCTSAALDH1A1GAAHPGD
SCHEMBL29780712 0.71 CES2 (0.53) ALDH1A1GAAKMT2AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2526098-B1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES HOFFMANN LA ROCHE (CH) 2018-07-11 EP disclosed
US-8470820-B2 Nitrogen-containing heteroaryl derivatives HOFFMAN-LA ROCHE INC. (US) 2013-06-25 US disclosed
CN-102712625-A Nitrogen-containing heteroaryl derivatives HOFFMANN LA ROCHE 2012-10-03 CN disclosed
US-20110183979-A1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-07-28 US disclosed
WO-2011089132-A1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183979-A1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES PDE3A, PDE2A, PDE10A MAPT 4445/4885CTSA 1817/4885ABL1 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.